Preliminary results of a Phase 1b, open-label, multicenter study of selgantolimod (GS-9688) in special populations of patients with chronic hepatitis B

被引：0
|
作者：
Agarwal, Kosh [1 ]
Cheng, Pin-Nan [2 ]
Liu, Chun-Jen [3 ,4 ]
Duan, Ran [5 ]
Kolhatkar, Nikita [5 ]
Mateo, Roberto [5 ]
Da, Ben [5 ]
Richards, Christopher [5 ]
Sowah, Leonard [5 ]
Fletcher, Simon [5 ]
Mendez, Patricia [5 ]
Chen, Chi-Yi [6 ]
Chuang, Wan-Long [7 ]
Holden Hsu, Yao-Chun [8 ,9 ]
机构：
[1] Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London, England
[2] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Tainan, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[5] Gilead Sci Inc, Foster City, CA USA
[6] Ditmanson Med Fdn Chiayi Christian Hosp, Div Gastroenterol & Hepatol, Dept Med, Chiayi, Taiwan
[7] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[8] E Da Hosp, Kaohsiung, Taiwan
[9] I Shou Univ, Kaohsiung, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-182
引用
收藏
页码：S1159 / S1160
页数：2
相关论文
共 50 条
  • [31] Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid-Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)
    Miklos, D.
    Cutler, C.
    Arora, M.
    Walker, E.
    Jagasia, M.
    Nakamura, R.
    Blazar, B.
    Juretic, M.
    Li, Y.
    Dubovsky, J.
    James, D.
    Styles, L.
    Jaglowski, S.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S176 - S177
  • [32] A phase 1b open-label multicenter study of AZD4547 in patients with advanced squamous cell lung cancers: Preliminary antitumor activity and pharmacodynamic data.
    Paik, Paul K.
    Shen, Ronglai
    Ferry, David
    Soria, Jean-Charles
    Mathewson, Alastair
    Kilgour, Elaine
    Landers, Donal
    Frewer, Paul
    Brooks, Nigel
    Andre, Fabrice
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study
    Cheah, Chan Yoon
    Belada, David
    Fanale, Michelle A.
    Janikova, Andrea
    Czucman, Myron S.
    Flinn, Ian W.
    Kapp, Amy V.
    Ashkenazi, Avi
    Kelley, Sean
    Bray, Gordon L.
    Holden, Scott
    Seymour, John F.
    [J]. LANCET HAEMATOLOGY, 2015, 2 (04): : E166 - E174
  • [34] Updated Results from a Multicenter, Open-Label, Dose-Escalation Phase 1b/2 Study of Single-Agent Oprozomib in Patients with Waldenstrom Macroglobulinemia (WM)
    Siegel, David S.
    Kaufman, Jonathan L.
    Raje, Noopur S.
    Mikhael, Joseph R.
    Kapoor, Prashant
    Treon, Steven P.
    Castillo, Jorge J.
    Neuman, Linda L.
    Lee, Ju RueyJiuan
    Ghobrial, Irene
    [J]. BLOOD, 2014, 124 (21)
  • [35] Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
    Felip, Enriqueta
    de Braud, Filippo G.
    Maur, Michela
    Loong, Herbert H.
    Shaw, Alice Tsang
    Vansteenkiste, Johan F.
    John, Thomas
    Liu, Geoffrey
    Lolkema, Martijn P.
    Selvaggi, Giovanni
    Giannone, Vanessa
    Cazorla, Pilar
    Baum, Jason
    Balbin, O. Alejandro
    Wang, Luojun
    Lau, Yvonne Y.
    Scott, Jeffrey W.
    Tan, Daniel Shao-Weng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : 392 - 403
  • [36] Immunogenicity and Safety of Hepatitis E Vaccine in Chronic Hepatitis B Patients: An Open-Label Control Study in China
    Zhang, Li
    [J]. HEPATOLOGY, 2018, 68 : 1181A - 1181A
  • [37] SUBCUTANEOUS DARATUMUMAB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): AN OPEN-LABEL, MULTICENTER, DOSE ESCALATION PHASE 1B STUDY (PAVO)
    Mateos, M., V
    Chari, A.
    Nah, H.
    Lokhorst, H.
    Kaufman, J. L.
    Moreau, P.
    Oriol, A.
    Plesner, T.
    Benboubker, L.
    Hellemans, P.
    Masterson, T.
    Clemens, P. L.
    Liu, K.
    San-Miguel, J.
    Usmani, S. Z.
    [J]. HAEMATOLOGICA, 2018, 103 : 32 - 33
  • [38] Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
    Ahmed, Kamran A.
    Kim, Youngchul
    Arrington, John A.
    Kim, Sungjune
    DeJesus, Michelle
    Soyano, Aixa E.
    Armaghani, Avan J.
    Costa, Ricardo L. B.
    Khong, Hung T.
    Loftus, Loretta S.
    Rosa, Marilin
    Caudell, Jimmy J.
    Diaz, Roberto
    Robinson, Timothy J.
    Etame, Arnold B.
    Tran, Nam D.
    Sahebjam, Solmaz
    Soliman, Hatem H.
    Czerniecki, Brian J.
    Forsyth, Peter A.
    Yu, H. Michael
    Han, Hyo S.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (06)
  • [39] Multicenter, nonrandomized, open-label Phase 1b study of FP-1039/GSK3052230 with chemotherapy: results in malignant pleural mesothelioma (MPM)
    Trigo Perez, J. M.
    van Brummelen, E.
    Levchenko, E.
    Gomez, M. Domine
    Fennell, D. A.
    Kindler, H. L.
    Viteri, S.
    Gadgeel, S.
    Lopez, P. Garrido
    Kostorov, V.
    Morgensztern, D.
    Orlov, S.
    Paik, P. K.
    Vansteenkiste, J. F.
    Wang, X.
    Sharabidze, A.
    Deyoung, M. P.
    Baker, K. P.
    Yan, L.
    Mitrica, I.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [40] Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis
    Lawitz, Eric
    Makara, Mihaly
    Akarca, Ulus Salih
    Thuluvath, Paul J.
    Preotescu, Li Liana Lucia
    Varunok, Peter
    Morillas, Rosa Ma.
    Hall, Coleen
    Mobashery, Niloufar
    Redman, Rebecca
    Pilot-Matias, Tami
    Vilchez, Regis A.
    Hezode, Christophe
    [J]. GASTROENTEROLOGY, 2015, 149 (04) : 971 - U678
12345